Alpha Diagnostic International, Inc. Human Adenosine receptor 2b (A2bR) Control/blocking peptide #1 A2bR23-P

Human Adenosine receptor 2b (A2bR) Control/blocking peptide #1 General Information The purine nucleoside adenosine modulates diverse physiological functions including induction of sedation, vasodilatation, suppression of cardiac rate and contractility, neurotransmitter release, inhibition of platelet aggregation and lipolysis. Adenosine SugApplications Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 16-aa peptide of Human A2BR/ADORA2B (1) (gene accession # P29275; Designated (A2BR23-P or control/blocking peptide). SugPositiveControl Brain, Kidney or other tissues or cells lines expressing the given adenosine receptor protein or Recombinant cells (bacterial or mammalian) with high level expression. SpCrossreactivity The human A2BR23-P peptide is conserved 87% in rabbit, 81% in canine, 75% in rat, and 62% in mouse A2bR sequences. Antibody to human A2bR shows crossreactivity with mouse and rat A2bR. Control peptide, because of its low mol. Wt (<3 kDa), is not suitable MSDS Contains no preservatives For research use only, not for diagnostic or therapeutic use.